Meta-analysis Systematically Evaluates Semaglutide's Safety and Efficacy in Schizophrenia Patients.
Semaglutide in Schizophrenia-A Top Clinical Trial.
Abstract
A systematic review and meta-analysis evaluated semaglutide's safety and efficacy profile in individuals with schizophrenia spectrum disorders, synthesizing evidence from RCTs.